Exposure–Response Analysis of the Sodium–Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes

Sodium–glucose cotransporter-2 (SGLT2) inhibitors improve markers for renal and cardiovascular outcomes in patients with and without type 2 diabetes (T2D). To assess whether individual differences in plasma drug exposure can explain inter-individual response variation, we characterized the exposure–...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Hoek, Sjoukje, Koomen, Jeroen V., van Bommel, Erik J. M., Mosterd, Charlotte M., Scholtes, Rosalie A., Hesp, Anne C., Stevens, Jasper, van Raalte, Daniel H., Heerspink, Hiddo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220852/
https://www.ncbi.nlm.nih.gov/pubmed/37240917
http://dx.doi.org/10.3390/jpm13050747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220852/
https://www.ncbi.nlm.nih.gov/pubmed/37240917
http://dx.doi.org/10.3390/jpm13050747

Ejemplares similares